Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Leys, R. B."'
Autor:
Groen, K., Seefat, M. R., van der Holt, B., Schjesvold, F. H., Stege, C. A., Levin, M.‐D., Hansson, M., Leys, R. B., Regelink, J., Waage, A., Szatkowski, D., Axelsson, P., Do, T. H., Svirskaite, A., van der Spek, E., Haukas, E., Knut‐Bojanowska, D., Ypma, P. F., Blimark, C., Mellqvist, U.‐H.
Publikováno v:
HemaSphere; 2022 Supplement 3, Vol. 6, p796-797, 2p
Autor:
LAMB, SUSAN
Publikováno v:
Journal of the History of the Behavioral Sciences. Spring2016, Vol. 52 Issue 2, p124-145. 22p.
Autor:
Langille, Barbara L., Hyde, Josephine, Saint, Kathleen M., Bradford, Tessa M., Stringer, Danielle N., Tierney, Simon M., Humphreys, William F., Austin, Andrew D., Cooper, Steven J. B.
Publikováno v:
Evolution; Jan2021, Vol. 75 Issue 1, p166-175, 10p
Autor:
Klaas G. van der Hem, Kaz Groen, Niels W.C.J. van de Donk, Amanda C. Dijk, Nicole C. H. P. van der Burg-de Graauw, Mark-David Levin, Kazem Nasserinejad, Henriette Levenga, Paula F. Ypma, Aart Beeker, L. Strobbe, Inger S. Nijhof, Harm Sinnige, Claudia A.M. Stege, Saskia K. Klein, Roel J. W. van Kampen, Gerjo A. Velders, Ad Koster, Mels Hoogendoorn, Rineke B. L. Leys, Matthijs Westerman, Gert-Jan Timmers, Pieter Sonneveld, Marjan A. Davidis-van Schoonhoven, Sonja Zweegman, Nazik Durdu-Rayman, Matthijs H Silbermann, Ellen van der Spek, Yavuz M. Bilgin
Publikováno v:
Leukemia, 35(9), 2715-2719. Nature Publishing Group
Stege, C A M, Nasserinejad, K, Klein, S K, Timmers, G J, Hoogendoorn, M, Ypma, P F, Nijhof, I S, Velders, G A, Strobbe, L, Durdu-Rayman, N, Westerman, M, Davidis-van Schoonhoven, M A, van Kampen, R J W, Beeker, A, Koster, A, Dijk, A C, van de Donk, N W C J, van der Spek, E, Leys, R B L, Silbermann, M H, Groen, K, van der Burg-de Graauw, N C H P, Sinnige, H A M, van der Hem, K G, Levenga, H, Bilgin, Y M, Sonneveld, P, Levin, M D & Zweegman, S 2021, ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ', Leukemia, vol. 35, no. 9, pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-z
Stege, C A M, Nasserinejad, K, Klein, S K, Timmers, G J, Hoogendoorn, M, Ypma, P F, Nijhof, I S, Velders, G A, Strobbe, L, Durdu-Rayman, N, Westerman, M, Davidis-van Schoonhoven, M A, van Kampen, R J W, Beeker, A, Koster, A, Dijk, A C, van de Donk, N W C J, van der Spek, E, Leys, R B L, Silbermann, M H, Groen, K, van der Burg-de Graauw, N C H P, Sinnige, H A M, van der Hem, K G, Levenga, H, Bilgin, Y M, Sonneveld, P, Levin, M D & Zweegman, S 2021, ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ', Leukemia, vol. 35, no. 9, pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c982e9f5732c38f73a830fb0c6796056
https://doi.org/10.1038/s41375-021-01162-z
https://doi.org/10.1038/s41375-021-01162-z
Autor:
Mels Hoogendoorn, Rineke B L Leys, Dana A. Chitu, Okke de Weerdt, Hanneke C. Kluin-Nelemans, Eva de Jongh, Rien van Marwijk Kooij, Robby E. Kibbelaar, Mars B. van 't Veer, Michel van Gelder, Monique C. Minnema, Marie Josee Kersten, Josée M. Zijlstra, Daphne de Jong, Jeanette K. Doorduijn, M.A. MacKenzie, Tjeerd J. F. Snijders, Pieternella J. Lugtenburg, Lara H Böhmer
Publikováno v:
Doorduijn, J K, Zijlstra, J M, Lugtenburg, P J, Kersten, M J, Böhmer, L H, Minnema, M C, MacKenzie, M A, van Marwijk Kooij, R, de Jongh, E, Snijders, T J F, de Weerdt, O, van Gelder, M, Hoogendoorn, M, Leys, R B L, Kibbelaar, R E, de Jong, D, Chitu, D A, Van’t Veer, M B & Kluin-Nelemans, H C 2020, ' Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial ', British Journal of Haematology, vol. 190, no. 3, pp. 385-393 . https://doi.org/10.1111/bjh.16567
British Journal of Haematology, 190(3), 385-393. Wiley
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell
British Journal of Haematology, 190, 3, pp. 385-393
British Journal of Haematology
British Journal of Haematology, 190, 385-393
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell Publishing Ltd
British journal of haematology, 190(3), 385-393. Wiley-Blackwell
British Journal of Haematology, 190(3), 385-393. Wiley
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell
British Journal of Haematology, 190, 3, pp. 385-393
British Journal of Haematology
British Journal of Haematology, 190, 385-393
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell Publishing Ltd
British journal of haematology, 190(3), 385-393. Wiley-Blackwell
Contains fulltext : 225496.pdf (Publisher’s version ) (Open Access) Rituximab-containing induction followed by autologous stem cell transplantation (ASCT) is the standard first-line treatment for young mantle cell lymphoma patients. However, most p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4ea79a8fe4dc5d93bcc8bbeecbc57
https://doi.org/10.1111/bjh.16567
https://doi.org/10.1111/bjh.16567
Publikováno v:
Simian Virology; 2009, p155-161, 7p
Publikováno v:
Simian Virology; 2009, p77-118, 42p
Autor:
Ellen van der Spek, Morten Salomo, Damian L. Szatkowski, Einar Haukås, Paula F. Ypma, Per Axelsson, Saskia K. Klein, Pino J Poddighe, Sonja Zweegman, Fredrik Schjesvold, Mark-David Levin, Marian Stevens-Kroef, Asta Svirskaite, Trung Hieu Do, Pieter Sonneveld, Markus Hansson, Claudia A.M. Stege, Dorota Knut-Bojanowska, Celine Blimark, Anja Klostergaard, Rineke B. L. Leys, Niels Abildgaard, Niels W.C.J. van de Donk, Bronno van der Holt, Anders Waage, Ulf-Henrik Mellqvist
Publikováno v:
Haematologica, 105, 12, pp. 2879-82
Zweegman, S, Stege, C A M, Haukas, E, Schjesvold, F H, Levin, M-D, Waage, A, Leys, R B L, Klein, S K, Szatkowski, D, Axelsson, P, Hieu Do, T, Knut-Bojanowska, D, van der Spek, E, Svirskaite, A, Klostergaard, A, Salomo, M, Blimark, C, Ypma, P F, Mellqvist, U-H, Poddighe, P J, Stevens-Kroef, M, van de Donk, N W C J, Sonneveld, P, Hansson, M, van der Holt, B & Abildgaard, N 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374
Haematologica, 105(12), 2879-2882. Ferrata Storti Foundation
Haematologica, 105, 2879-82
Haematologica
Sonja Zweegman, Z, Claudia A M Stege, A M S, Einar Haukas, H, Fredrik H Schjesvold, H S, Mark-David Levin, L, Anders Waage, W, Rineke B L Leys, B L L, Saskia K Klein, K K, Damian Szatkowski, S, Per Axelsson, A, Trung Hieu Do, H D, Dorota Knut-Bojanowska, K-B, Ellen van der Spek, V D S, Asta Svirskaite, S, Klostergaard, A, Morten Salomo, S, Celine Blimark, B, Paula F Ypma, F Y, Ulf-Henrik Mellqvist, M, Pino J Poddighe, J P, Marian Stevens-Kroef, S-K, Niels W C J van de Donk, W C J V D D, Pieter Sonneveld, S, Markus Hansson, H, Bronno van der Holt, V D H & Niels Abildgaard, A 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374
Zweegman, S, Stege, C A M, Haukas, E, Schjesvold, F H, Levin, M-D, Waage, A, Leys, R B L, Klein, S K, Szatkowski, D, Axelsson, P, Hieu Do, T, Knut-Bojanowska, D, van der Spek, E, Svirskaite, A, Klostergaard, A, Salomo, M, Blimark, C, Ypma, P F, Mellqvist, U-H, Poddighe, P J, Stevens-Kroef, M, van de Donk, N W C J, Sonneveld, P, Hansson, M, van der Holt, B & Abildgaard, N 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374
Haematologica, 105(12), 2879-2882. Ferrata Storti Foundation
Haematologica, 105, 2879-82
Haematologica
Sonja Zweegman, Z, Claudia A M Stege, A M S, Einar Haukas, H, Fredrik H Schjesvold, H S, Mark-David Levin, L, Anders Waage, W, Rineke B L Leys, B L L, Saskia K Klein, K K, Damian Szatkowski, S, Per Axelsson, A, Trung Hieu Do, H D, Dorota Knut-Bojanowska, K-B, Ellen van der Spek, V D S, Asta Svirskaite, S, Klostergaard, A, Morten Salomo, S, Celine Blimark, B, Paula F Ypma, F Y, Ulf-Henrik Mellqvist, M, Pino J Poddighe, J P, Marian Stevens-Kroef, S-K, Niels W C J van de Donk, W C J V D D, Pieter Sonneveld, S, Markus Hansson, H, Bronno van der Holt, V D H & Niels Abildgaard, A 2020, ' Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial ', Haematologica, vol. 105, no. 12, pp. 2879-2882 . https://doi.org/10.3324/haematol.2019.240374
Contains fulltext : 229254.pdf (Publisher’s version ) (Open Access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0355ddccdcad64c6d512a5e716350e5d
https://hdl.handle.net/2066/229254
https://hdl.handle.net/2066/229254
